サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1361765

移植薬物モニタリングアッセイの世界市場レポート

Global Transplant Drug Monitoring Assay Market Report
出版日: | 発行: Value Market Research | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
移植薬物モニタリングアッセイの世界市場レポート
出版日: 2023年10月01日
発行: Value Market Research
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植薬物モニタリングアッセイ市場の世界需要は、2023年～2030年の調査期間中にCAGR13.12%で成長し、2022年の2億1,272万米ドルから2030年までに6億4,520万米ドル近い市場規模に達すると推定されます。

移植薬物モニタリングアッセイは、医療専門家が免疫抑制剤の血漿中および血中濃度をそれぞれの治療範囲内に維持するために極めて重要です。移植薬物モニタリングアッセイは、投薬の開始とともに始まる。これには、患者や年齢、肥満度、体重、臓器機能、薬物療法などの臨床状態の特徴に許容される予備的な投与レジメンの決定が含まれます。

市場力学：

市場成長の要因は、臓器移植需要の増加、研究開発資金の増加、腎臓病などの慢性疾患の有病率の増加です。さらに、ポイントオブケアの治療薬モニタリングや在宅ベースの治療薬モニタリングのニーズの増加は、予測期間中、世界の移植薬物モニタリングアッセイ業界で事業を展開する企業に有利な市場機会を提供する可能性が高いです。さらに、ヘルスケア支出の増加、ヘルスケアインフラの改善、世界の一人当たり所得の増加、政府の償還プログラムは、今後数年間、移植薬物モニタリングアッセイ市場に有益な見通しを提示すると予測されています。しかし、莫大な投資の必要性や小規模病院が移植薬物モニタリングアッセイサービスの提供に消極的であることが、市場成長の妨げになる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは移植薬物モニタリングアッセイの世界市場における各セグメントを包括的に評価することもできます。移植薬物モニタリングアッセイ産業の成長と動向は、この調査への全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける移植薬物モニタリングアッセイ市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、このレポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタムメイドのご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 移植薬物モニタリングアッセイ：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 移植薬物モニタリングアッセイの世界市場分析：製品別

  • 概要：製品別
  • 実績データと予測データ
  • 分析：製品別
  • 装置
  • 消耗品（クロマトグラフィー＆MS検出器、免疫測定分析装置、臨床化学分析装置）

第7章 移植薬物モニタリングアッセイの世界市場分析：技術別

  • 概要：技術別
  • 実績データと予測データ
  • 分析：技術別
  • クロマトグラフィーMS
  • イムノアッセイ

第8章 移植薬物モニタリングアッセイの世界市場分析：薬剤別

  • 概要：薬剤別
  • 実績データと予測データ
  • 分析：薬剤別
  • タクロリムス
  • メトトレキサート
  • シクロスポリン
  • その他

第9章 移植薬物モニタリングアッセイの世界市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 実績データと予測データ
  • 分析：エンドユーザー別
  • 病院検査室
  • 商業・民間研究所
  • その他

第10章 移植薬物モニタリングアッセイの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第11章 移植薬物モニタリングアッセイ企業の競合情勢

  • 移植薬物モニタリングアッセイ市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業シェア分析
  • 市場集中度
  • Abbott
  • Thermo Fisher Scientific Inc.
  • H.U. Group Holdings Inc.
  • Fujirebio Holdings Inc.
  • Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Hologic Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories Inc.
  • Other Prominent Players
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Chromatography-MS Market Sales by Geography (USD MN)
  • Immunoassays Market Sales by Geography (USD MN)
  • Analysis by Drug (USD MN)
  • Tacrolimus Market Sales by Geography (USD MN)
  • Methotrexate Market Sales by Geography (USD MN)
  • Cyclosporin Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospital Laboratories Market Sales by Geography (USD MN)
  • Commercial & Private Laboratories Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Transplant Drug Monitoring Assay Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Transplant Drug Monitoring Assay Report
  • Market Research Process
  • Market Research Methodology
  • Global Transplant Drug Monitoring Assay Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Drug
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis Product (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Chromatography-MS Market Sales by Geography (USD MN)
  • Immunoassays Market Sales by Geography (USD MN)
  • Global Market Analysis by Drug (USD MN)
  • Tacrolimus Market Sales by Geography (USD MN)
  • Methotrexate Market Sales by Geography (USD MN)
  • Cyclosporin Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospital Laboratories Market Sales by Geography (USD MN)
  • Commercial & Private Laboratories Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218699

The global demand for Transplant Drug Monitoring Assay Market is presumed to reach the market size of nearly USD 645.2 MN by 2030 from USD 212.72 MN in 2022 with a CAGR of 13.12% under the study period 2023 - 2030.

Transplant drug monitoring assay is crucial in helping health care professionals maintain plasma and blood levels of immunosuppressants within their respective therapeutic ranges. Transplant drug monitoring assay starts with the initiation of medication. It includes the determination of a preliminary dosage regimen acceptable for the patient and clinical state characteristics such as age, body mass index, weight, organ function and drug therapy.

MARKET DYNAMICS:

The factors fueling the market growth are the increased demand for organ transplants, increased R&D funding, and an increase in the prevalence of chronic diseases such as kidney diseases. Moreover, an increase in the need for point-of-care therapeutic drug monitoring and home-based therapeutic drug monitoring is likely to offer lucrative market opportunities for players operating in the global transplant drug monitoring assay industry during the forecast period. Additionally, a rise in healthcare expenditure, improvement in healthcare infrastructure, increase in global per capita income, and government reimbursement programs are projected to present profitable prospects in the transplant drug monitoring assay market in the upcoming years. However, the need for huge investments and the reluctance of small hospitals to offer transplant drug monitoring assay services may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transplant drug monitoring assay. The growth and trends of transplant drug monitoring assay industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the transplant drug monitoring assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Equipment
  • Consumables (Chromatography & Ms Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers)

By Technology

  • Chromatography-Ms
  • Immunoassays

By Drug

  • Tacrolimus
  • Methotrexate
  • Cyclosporin
  • Others

By End-User

  • Hospital Laboratories
  • Commercial & Private Laboratories
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Transplant Drug Monitoring Assay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transplant Drug Monitoring Assay market include Abbott, Thermo Fisher Scientific Inc., H.U. Group Holdings Inc. (Fujirebio Holdings, Inc.), Hoffmann-La Roche Ltd., Siemens Healthineers AG, Hologic Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Other prominent players. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . TRANSPLANT DRUG MONITORING ASSAY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Drug
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Equipment Historic and Forecast Sales by Regions
  • 6.5 Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Historic and Forecast Sales by Regions

7 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY TECHNOLOGY

  • 7.1 Overview by Technology
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technology
  • 7.4 Chromatography-MS Historic and Forecast Sales by Regions
  • 7.5 Immunoassays Historic and Forecast Sales by Regions

8 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY DRUG

  • 8.1 Overview by Drug
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Drug
  • 8.4 Tacrolimus Historic and Forecast Sales by Regions
  • 8.5 Methotrexate Historic and Forecast Sales by Regions
  • 8.6 Cyclosporin Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY END-USER

  • 9.1 Overview by End-user
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-user
  • 9.4 Hospital Laboratories Historic and Forecast Sales by Regions
  • 9.5 Commercial & Private Laboratories Historic and Forecast Sales by Regions
  • 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE TRANSPLANT DRUG MONITORING ASSAY COMPANIES

  • 11.1. Transplant Drug Monitoring Assay Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF TRANSPLANT DRUG MONITORING ASSAY INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Abbott
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Thermo Fisher Scientific Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. H.U. Group Holdings Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Fujirebio Holdings Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Hoffmann-La Roche Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Siemens Healthineers AG
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Hologic Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Danaher Corporation
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Bio-Rad Laboratories Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Other Prominent Players
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies